Common use of Ongoing Activities Clause in Contracts

Ongoing Activities. Licensor will, at ▇▇▇▇▇▇▇’▇ election, wind down, complete or transfer to ▇▇▇▇▇▇▇ any Development activity relating to the Licensed Compounds and Licensed Products that is ongoing on the Effective Date, except that (a) Licensor will have the right to complete the activities set forth in Schedule 2.1.3 (the “Ongoing Pre-Clinical Studies”) and (b) Licensor will have the right to conduct the Phase 2 MS POC Study in accordance with Section 3.4. Promptly after completion of each Ongoing Pre-Clinical Study (and at any other time upon ▇▇▇▇▇▇▇’▇ request), Licensor will deliver to ▇▇▇▇▇▇▇ all clinical and non-clinical data related to the Licensed Compounds and Licensed Products (including the raw tables, figures and listings datasets) generated from such study and all analyses and reports (including interim and final study reports) relating to any such data.